⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23806902 | 0.81 | CYP2D6 (0.44) | — | |
| SCHEMBL25833008 | 0.80 | EPHX1 (0.34) | — | |
| SCHEMBL25726118 | 0.79 | KCNH2 (0.32) | — | |
| SCHEMBL26246996 | 0.78 | HRH3 (0.32) | — | |
| SCHEMBL23945976 | 0.75 | NAMPT (0.36) | — | |
| SCHEMBL25816821 | 0.75 | — | — | |
| SCHEMBL25468601 | 0.73 | CYP2D6 (0.38) | — | |
| SCHEMBL26455588 | 0.72 | CYP2D6 (0.37) | — | |
| SCHEMBL22856408 | 0.72 | NAMPT (0.36) | — | |
| SCHEMBL25728446 | 0.72 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352350-B2 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2022-06-07 | — | — | US | disclosed |
| US-20210323952-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2021-10-21 | — | — | US | disclosed |